299 related articles for article (PubMed ID: 28331826)
1. Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology.
Gao JW; Rizzo S; Ma LH; Qiu XY; Warth A; Seki N; Hasegawa M; Zou JW; Li Q; Femia M; Lv TF; Song Y;
Transl Lung Cancer Res; 2017 Feb; 6(1):68-75. PubMed ID: 28331826
[TBL] [Abstract][Full Text] [Related]
2. Correlation exploration among CT imaging, pathology and genotype of pulmonary ground-glass opacity.
Cai Y; Chen T; Zhang S; Tan M; Wang J
J Cell Mol Med; 2023 Jul; 27(14):2021-2031. PubMed ID: 37340599
[TBL] [Abstract][Full Text] [Related]
3. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
4. Multislice spiral computed tomography in the differential diagnosis of ground-glass opacity.
Yu J; Zhu S; Ge Z; Shen B; Shen Y; Wang C; Fang X; Dai J
J Cancer Res Ther; 2018 Jan; 14(1):128-132. PubMed ID: 29516974
[TBL] [Abstract][Full Text] [Related]
5. Impact of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage IA adenocarcinoma of the lung: Correlation between computed tomography images and EGFR and KRAS gene mutations.
Wang T; Zhang T; Han X; Liu XI; Zhou N; Liu Y
Exp Ther Med; 2015 Jun; 9(6):2095-2103. PubMed ID: 26136941
[TBL] [Abstract][Full Text] [Related]
6. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
[TBL] [Abstract][Full Text] [Related]
7. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
[TBL] [Abstract][Full Text] [Related]
8. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
Zhang Y; Fu F; Chen H
Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
[TBL] [Abstract][Full Text] [Related]
9. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
Kobayashi Y; Mitsudomi T
Transl Lung Cancer Res; 2013 Oct; 2(5):354-63. PubMed ID: 25806254
[TBL] [Abstract][Full Text] [Related]
10. Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma.
Zhao M; Zhan C; Li M; Yang X; Yang X; Zhang Y; Lin M; Xia Y; Feng M; Wang Q
J Thorac Dis; 2018 Jan; 10(1):398-407. PubMed ID: 29600072
[TBL] [Abstract][Full Text] [Related]
11. Radiomic analysis of pulmonary ground-glass opacity nodules for distinction of preinvasive lesions, invasive pulmonary adenocarcinoma and minimally invasive adenocarcinoma based on quantitative texture analysis of CT.
Li W; Wang X; Zhang Y; Li X; Li Q; Ye Z
Chin J Cancer Res; 2018 Aug; 30(4):415-424. PubMed ID: 30210221
[TBL] [Abstract][Full Text] [Related]
12. Ground glass opacities: Imaging, pathology, and gene mutations.
Sun F; Xi J; Zhan C; Yang X; Wang L; Shi Y; Jiang W; Wang Q
J Thorac Cardiovasc Surg; 2018 Aug; 156(2):808-813. PubMed ID: 29753514
[TBL] [Abstract][Full Text] [Related]
13. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
[TBL] [Abstract][Full Text] [Related]
14. Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis.
Ortiz AFH; Camacho TC; Vásquez AF; Del Castillo Herazo V; Neira JGA; Yepes MM; Camacho EC
Eur J Radiol Open; 2022; 9():100400. PubMed ID: 35198656
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation.
Lu CH; Hsiao CH; Chang YC; Lee JM; Shih JY; Wu LA; Yu CJ; Liu HM; Shih TT; Yang PC
J Thorac Oncol; 2012 Jan; 7(1):143-50. PubMed ID: 22124475
[TBL] [Abstract][Full Text] [Related]
16. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
Glynn C; Zakowski MF; Ginsberg MS
J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
[TBL] [Abstract][Full Text] [Related]
17. Molecular typing of lung adenocarcinoma with computed tomography and CT image-based radiomics: a narrative review of research progress and prospects.
Ma JW; Li M
Transl Cancer Res; 2021 Sep; 10(9):4217-4231. PubMed ID: 35116717
[TBL] [Abstract][Full Text] [Related]
18. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.
Li F; Sone S; Abe H; Macmahon H; Doi K
Radiology; 2004 Dec; 233(3):793-8. PubMed ID: 15498895
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive characterization of genomic and radiologic features reveals distinct driver patterns of RTK/RAS pathway in ground-glass opacity pulmonary nodules.
Yu F; Peng M; Bai J; Zhu X; Zhang B; Tang J; Liu W; Chen C; Wang X; Chen M; Tan S; Sun Y; Liang Q; Li J; Hu Y; Liao A; Hu H; He Y; Xiao X; Wang B; Xing G; Xu Y; Chen R; Xia X; Chen X
Int J Cancer; 2022 Dec; 151(11):2020-2030. PubMed ID: 36029220
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Blood Supply Status of the Focal Ground-Glass Opacity in Lungs Using Spectral Computed Tomography.
Liu G; Li M; Li G; Li Z; Liu A; Pu R; Cao H; Liu Y
Korean J Radiol; 2018; 19(1):130-138. PubMed ID: 29354009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
